This inventor holds 1 USPTO granted patent. Top assignee: Kingdom of the Netherlands. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: **Innovator Spotlight: Wolfgang Reischl**
Introduction
Wolfgang Reischl, an esteemed inventor based in Weesp, Netherlands, has made significant contributions to the field of pharmaceutical sciences. With a strong focus on vitamin D analogs, his innovative work emphasizes the development of new compounds that have potential applications in both pharmacotherapy and cosmetics.
Latest Patents
Reischl holds a patent for "Vitamin D analogs and methods of preparing these compounds." This invention pertains to vitamin D analogs represented by a general formula that includes various substituents. These compounds are noteworthy for their incorporation of hydroxyl groups and various aliphatic hydrocarbon chains. The patent outlines methods of synthesizing these analogs and details their uses in medicinal and cosmetic formulations.
Career Highlights
Throughout his career, Wolfgang Reischl has dedicated himself to research and innovation in the pharmaceutical sector. His patent not only highlights his expertise in organic chemistry but also showcases his commitment to improving health outcomes through scientifically advanced solutions. He is affiliated with the Kingdom of the Netherlands.
Collaborations
Reischl has collaborated with fellow researchers, including Sebastianus J Halkes and Jan Paul Van De Velde. These partnerships enhance the scope of his innovations and underline the collaborative spirit that drives advancements in the field of pharmacotherapy.
Conclusion
Wolfgang Reischl stands out as a pioneering inventor in the realm of vitamin D analogs, with a substantial patent that reflects his innovative approach to healthcare. His work not only advances pharmaceutical technologies but also demonstrates the importance of collaboration in achieving groundbreaking results.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile